FR2543829B1 - Preparations therapeutiques a base de nouveaux derives de la furo-(3,4-c)-pyridine - Google Patents

Preparations therapeutiques a base de nouveaux derives de la furo-(3,4-c)-pyridine

Info

Publication number
FR2543829B1
FR2543829B1 FR8404807A FR8404807A FR2543829B1 FR 2543829 B1 FR2543829 B1 FR 2543829B1 FR 8404807 A FR8404807 A FR 8404807A FR 8404807 A FR8404807 A FR 8404807A FR 2543829 B1 FR2543829 B1 FR 2543829B1
Authority
FR
France
Prior art keywords
pyridine derivatives
preparations based
therapeutic preparations
furo
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8404807A
Other languages
English (en)
French (fr)
Other versions
FR2543829A1 (fr
Inventor
Andre Esanu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838327815A external-priority patent/GB8327815D0/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of FR2543829A1 publication Critical patent/FR2543829A1/fr
Application granted granted Critical
Publication of FR2543829B1 publication Critical patent/FR2543829B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR8404807A 1983-04-05 1984-03-28 Preparations therapeutiques a base de nouveaux derives de la furo-(3,4-c)-pyridine Expired FR2543829B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8309165 1983-04-05
GB838327815A GB8327815D0 (en) 1983-10-18 1983-10-18 Furo-(3 4-c)-pyridine derivatives

Publications (2)

Publication Number Publication Date
FR2543829A1 FR2543829A1 (fr) 1984-10-12
FR2543829B1 true FR2543829B1 (fr) 1986-11-21

Family

ID=26285725

Family Applications (2)

Application Number Title Priority Date Filing Date
FR8404807A Expired FR2543829B1 (fr) 1983-04-05 1984-03-28 Preparations therapeutiques a base de nouveaux derives de la furo-(3,4-c)-pyridine
FR8404806A Expired FR2543956B1 (fr) 1983-04-05 1984-03-28 Derives de la furo-(3,4-c)-pyridine ainsi que leur preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8404806A Expired FR2543956B1 (fr) 1983-04-05 1984-03-28 Derives de la furo-(3,4-c)-pyridine ainsi que leur preparation

Country Status (29)

Country Link
US (1) US4581363A (enExample)
JP (1) JPS59193888A (enExample)
KR (1) KR900005518B1 (enExample)
AU (1) AU582113B2 (enExample)
CA (1) CA1257269A (enExample)
CH (1) CH660191A5 (enExample)
DE (1) DE3412885C2 (enExample)
DK (1) DK157931C (enExample)
DZ (1) DZ629A1 (enExample)
EG (1) EG18150A (enExample)
ES (1) ES8601998A1 (enExample)
FI (1) FI76804C (enExample)
FR (2) FR2543829B1 (enExample)
GR (1) GR79577B (enExample)
HK (1) HK11187A (enExample)
IE (1) IE57424B1 (enExample)
IL (1) IL71243A (enExample)
IN (1) IN160104B (enExample)
IT (1) IT1173770B (enExample)
LU (1) LU85262A1 (enExample)
MA (1) MA20084A1 (enExample)
MX (1) MX167397B (enExample)
MY (1) MY8600664A (enExample)
NL (1) NL190328C (enExample)
NO (1) NO161802C (enExample)
NZ (1) NZ207552A (enExample)
OA (1) OA07699A (enExample)
PT (1) PT78361B (enExample)
SE (1) SE458362B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
BR0008857A (pt) 1999-03-08 2001-12-18 Medicure Inc Análogos de piridoxal para distúrbios da vitaminab-6
EP1196171A2 (en) 1999-07-13 2002-04-17 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
US6677356B1 (en) * 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
PT1268498E (pt) 2000-02-29 2005-07-29 Medicure Int Inc Fosfonatos cardioprotectores
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
CN101014357A (zh) * 2004-07-07 2007-08-08 麦迪库瑞国际公司 利用血小板聚集药物的组合疗法
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7812037B2 (en) * 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2008582B (en) * 1977-11-25 1982-04-28 Scras Pyridine derivative
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (enExample) * 1981-02-10 1985-11-09 Scras

Also Published As

Publication number Publication date
MY8600664A (en) 1986-12-31
NO161802C (no) 1989-09-27
MX167397B (es) 1993-03-22
SE8401841D0 (sv) 1984-04-03
FI76804B (fi) 1988-08-31
FI841273A0 (fi) 1984-03-30
IT1173770B (it) 1987-06-24
DZ629A1 (fr) 2004-09-13
CH660191A5 (fr) 1987-03-31
SE8401841L (sv) 1984-10-06
AU2640184A (en) 1984-10-11
FI76804C (fi) 1988-12-12
NL190328C (nl) 1994-01-17
IE57424B1 (en) 1992-09-09
FR2543829A1 (fr) 1984-10-12
DK178084A (da) 1984-10-06
IE840826L (en) 1984-10-05
DK178084D0 (da) 1984-04-04
PT78361B (en) 1986-05-28
MA20084A1 (fr) 1984-12-31
AU582113B2 (en) 1989-03-16
DE3412885C2 (de) 1990-10-04
KR900005518B1 (ko) 1990-07-30
OA07699A (fr) 1985-08-30
DE3412885A1 (de) 1984-10-11
NZ207552A (en) 1986-05-09
HK11187A (en) 1987-02-13
EG18150A (en) 1992-08-30
NL8401013A (nl) 1984-11-01
LU85262A1 (fr) 1984-10-24
IN160104B (enExample) 1987-06-27
ES531285A0 (es) 1985-11-01
SE458362B (sv) 1989-03-20
FI841273L (fi) 1984-10-06
FR2543956A1 (fr) 1984-10-12
PT78361A (en) 1984-05-01
KR840008651A (ko) 1984-12-17
NO841322L (no) 1984-10-08
GR79577B (enExample) 1984-10-30
IL71243A (en) 1987-12-20
ES8601998A1 (es) 1985-11-01
FR2543956B1 (fr) 1986-07-04
NL190328B (nl) 1993-08-16
DK157931C (da) 1990-08-27
DK157931B (da) 1990-03-05
IT8420396A0 (it) 1984-04-05
IL71243A0 (en) 1984-06-29
CA1257269A (en) 1989-07-11
US4581363A (en) 1986-04-08
JPS59193888A (ja) 1984-11-02
JPH0556353B2 (enExample) 1993-08-19
NO161802B (no) 1989-06-19

Similar Documents

Publication Publication Date Title
FR2543829B1 (fr) Preparations therapeutiques a base de nouveaux derives de la furo-(3,4-c)-pyridine
FI890282L (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FR2559062B1 (fr) Medicaments a base de nouveaux derives 6-substitues de la furo-(3,4-c)-pyridine
FI895509A0 (fi) Terapeutiskt redskap.
NO167034C (no) Fremgangsmaate for fremstilling av 1,6-diklor-1,6-dideoksy-beta-d-fruktofuranosyl-4-kloro-4-dioksy-alfa-galactopyranosid
DK81091D0 (da) Imidazooe4,5-baaguinolin-2-thionderivater
FR2554719B1 (fr) Medicaments a base de nouveaux derives de la vinyl-6 furo-(3,4-c)-pyridine
FI862688L (fi) Pyridonkarboxylsyraderivat.
DE3669876D1 (de) 3,4-dihydrobenzopyranderivate.
FR2555049B1 (fr) Medicaments a base de carboxymethoxy-7 furo-(3,4-c)-pyridine
KR900700567A (ko) 2,3-디플루오로비페닐
FI862124A7 (fi) Morfiinijohdannaisia.
DK615186D0 (da) Substituerede 5,6-dialkoxyquinazolinderivater
FI894629A7 (fi) Uusia 3,4-diaminokinoliini- ja -pyridiiniyhdisteitä
NO872778L (no) Nye 4-pyridonderivater samt fremgangsmŸte for fremstilling derav.
FR2553286B1 (fr) Compositions therapeutiques a base de nouveaux derives de la chloro-4-furo-(3,4-c)-pyridine
DK598284D0 (da) 4,5,6,7-tetrahydrothiazolo(5,4-c)pyridinderivater
KR900700568A (ko) 2,3-디플루오로벤조산 유도체
DK505684A (da) 1,2-dithiolanderivater
FR2572285B1 (fr) Medicaments a base de nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine
KR860005812A (ko) 4,4-디알킬-2-아제티디논의 제조 방법
FI861951A7 (fi) 1,3-oxatianderivat.
FR2571965B1 (fr) Medicaments a base de nouveaux derives de la 4 h-dioxino-(4,5-c)-pyridine.
DE3469732D1 (de) 3,5-dialkyl-4-hydroxyphenyl-substituted derivatives
FR2569562B1 (fr) Compositions therapeutiques a base de nouveaux derives de l'aminomethyle-6 furo-(3,4-c)-pyridine

Legal Events

Date Code Title Description
ST Notification of lapse